Long-Term Effect of Dipeptidyl Peptidase-IV Inhibitors on Cardiovascular Events in Type 2 Diabetes Mellitus Middle-Age Patients: A Meta-Analysis

被引：0
|
作者：
Patel, Samir [1 ]
Patel, Palak [2 ]
Patel, Mihir [3 ]
机构：
[1] Western Reserve Hlth Educ, NEOMED, Youngstown, OH USA
[2] Qingdao Med Coll, Qingdao, Peoples R China
[3] St Marys Hosp, Waterbury, CT USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0971
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomised controlled trials
    Sakurai, R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 43 - 43
  • [22] Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials
    Xin, Li
    Sun, Shusen
    Wang, Jinwen
    Lu, Wenchao
    Wang, Tiansheng
    Tang, Huilin
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) : 106 - 108
  • [23] Cardiovascular safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: meta-analysis of randomised clinical trials
    De Berardis, G.
    Pellegrini, F.
    Scardapane, M.
    Lucisano, G.
    Hazell, L.
    Pladevall, M.
    Scotti, L.
    Varas-Lorenzo, C.
    Perez-Gutthann, S.
    Sturkenboom, M.
    Nicolucci, A.
    DIABETOLOGIA, 2014, 57 : S362 - S362
  • [24] Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis
    Wang, Ting
    Zhang, Xin
    Liu, Jian
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (02) : 84 - 93
  • [25] The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety
    Green, Jennifer B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 54 - 61
  • [26] To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus
    Andres, Julia
    Yeo, Jia Xuan
    Khoo, Chin Meng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S123 - S124
  • [27] Erroneous Event Count in a Meta-Analysis (Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus) Reply
    Albadarin, Firas
    Bell, David S. H.
    O'Keefe, James H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (06): : 852 - 853
  • [28] Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Esaki, Hiroki
    Tachi, Tomoya
    Goto, Chitoshi
    Sugita, Ikuto
    Kanematsu, Yuta
    Yoshida, Aki
    Saito, Kosuke
    Noguchi, Yoshihiro
    Ohno, Yuki
    Aoyama, Satoshi
    Yasuda, Masahiro
    Mizui, Takashi
    Yamamura, Masumi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [29] Effect of dipeptidyl peptidase-4 inhibitors on fracture risk in patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials
    Adil, Mohammad
    Ahmad, Tufail
    Sharma, Manju
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 379 - 380
  • [30] Impact of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis
    Yang, Jun
    Wu, Shanshan
    Xu, Yang
    Cai, Ting
    Yang, Zhirong
    Zhan, Siyan
    Sun, Feng
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 4 - 5
12345